Zosano Pharma

Developer of transdermal drug delivery systems for a broad range of therapeutic indications

placeFremont, California, United States calendar_todayFounded 2006 groups40 employees language zosanopharma.com

Registered entities

Innovation

7 patent families (2 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 445 times.

YearFilings
20152
20181
20191
20201
20214
20221
20241

Investor mix

11 investors on record; lead investors include Nomura, New Enterprise Associates, ProQuest Investments, HBM Healthcare Investments; 2 have since exited.

Investor typeCountShare
Venture capital545%
Private equity218%
Bank & private debt327%
Other / undisclosed19%
Coming soon